ARRIVENT BIOPHARMA INC. - COMMON STOCK
33.28
12-November-24 14:24:51
15 minutes delayed
Stocks
-1.06
-3.07%
Today's range
32.81 - 34.35
ISIN
N/A
Source
NASDAQ
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
12 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 May 2024 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >